Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_244196dc536fae48c044ff395608cb0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3546e17f2a9cba254b0b7775a889dd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2150942a106a01671eb30888d21e35b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_790e69f202d30702312797a3deaa6eb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_831fb22d79357ca39f4b07cc0156c863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b96cc1b38aad30c7997eba0e74e63bdb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
filingDate |
2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436f0aaf9165cf1ade44135a12ca151e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a21ae2aa68c9efe7603910b62f39cee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49066e3588280717d4b57390eac44775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bba898a4fc9c7f5b1ce04773d2e0f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d035046b178df422827f7d4e61581eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33bf2be9c0484b8e804e08cc4529f3b0 |
publicationDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007123542-A1 |
titleOfInvention |
Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds |
abstract |
The present invention relates to substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds of Formula (I) n n nand pharmaceutically acceptable forms thereof, as α 1a /α 1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment. |
priorityDate |
2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |